Epigenetic acquisition of inducibility of type III cytotoxicity in <it>P. aeruginosa</it>

<p>Abstract</p> <p>Background</p> <p><it>Pseudomonas aeruginosa</it>, an opportunistic pathogen, is often encountered in chronic lung diseases such as cystic fibrosis or chronic obstructive pneumonia, as well as acute settings like mechanical ventilation acq...

Full description

Bibliographic Details
Main Authors: Guery Benoit, LeBerre Rozenne, Comet Jean-Paul, Bernot Gilles, Mérieau Annabelle, Filopon Didier, Polack Benoit, Guespin-Michel Janine
Format: Article
Language:English
Published: BMC 2006-05-01
Series:BMC Bioinformatics
Online Access:http://www.biomedcentral.com/1471-2105/7/272
id doaj-dfcf984e276d4a50a7920ca69cfc109f
record_format Article
spelling doaj-dfcf984e276d4a50a7920ca69cfc109f2020-11-25T00:37:00ZengBMCBMC Bioinformatics1471-21052006-05-017127210.1186/1471-2105-7-272Epigenetic acquisition of inducibility of type III cytotoxicity in <it>P. aeruginosa</it>Guery BenoitLeBerre RozenneComet Jean-PaulBernot GillesMérieau AnnabelleFilopon DidierPolack BenoitGuespin-Michel Janine<p>Abstract</p> <p>Background</p> <p><it>Pseudomonas aeruginosa</it>, an opportunistic pathogen, is often encountered in chronic lung diseases such as cystic fibrosis or chronic obstructive pneumonia, as well as acute settings like mechanical ventilation acquired pneumonia or neutropenic patients. It is a major cause of mortality and morbidity in these diseases. In lungs, <it>P. aeruginosa </it>settles in a biofilm mode of growth with the secretion of exopolysaccharides in which it is encapsulated, enhancing its antibiotic resistance and contributing to the respiratory deficiency of patients. However, bacteria must first multiply to a high density and display a cytotoxic phenotype to avoid the host's defences. A virulence determinant implicated in this step of infection is the type III secretion system (TTSS), allowing toxin injection directly into host cells. At the beginning of the infection, most strains isolated from patients' lungs possess an inducible TTSS allowing toxins injection or secretion upon <it>in vivo </it>or <it>in vitro </it>activation signals. As the infection persists most of the bacteria permanently loose this capacity, although no mutations have been evidenced. We name "non inducible" this phenotype. As suggested by the presence of a positive feedback circuit in the regulatory network controlling TTSS expression, it may be due to an epigenetic switch allowing heritable phenotypic modifications without genotype's mutations.</p> <p>Results</p> <p>Using the generalised logical method, we designed a minimal model of the TTSS regulatory network that could support the epigenetic hypothesis, and studied its dynamics which helped to define a discriminating experimental scenario sufficient to validate the epigenetic hypothesis. A mathematical framework based on formal methods from computer science allowed a rigorous validation and certification of parameters of this model leading to epigenetic behaviour. Then, we demonstrated that a non inducible strain of <it>P. aeruginosa </it>can stably acquire the capacity to be induced by calcium depletion for the TTSS after a short pulse of a regulatory protein. Finally, the increased cytotoxicity of a strain after this epigenetic switch was demonstrated <it>in vivo </it>in an acute pulmonary infection model.</p> <p>Conclusion</p> <p>These results may offer new perspectives for therapeutic strategies to prevent lethal infections by <it>P. aeruginosa </it>by reverting the epigenetic inducibility of type III cytotoxicity.</p> http://www.biomedcentral.com/1471-2105/7/272
collection DOAJ
language English
format Article
sources DOAJ
author Guery Benoit
LeBerre Rozenne
Comet Jean-Paul
Bernot Gilles
Mérieau Annabelle
Filopon Didier
Polack Benoit
Guespin-Michel Janine
spellingShingle Guery Benoit
LeBerre Rozenne
Comet Jean-Paul
Bernot Gilles
Mérieau Annabelle
Filopon Didier
Polack Benoit
Guespin-Michel Janine
Epigenetic acquisition of inducibility of type III cytotoxicity in <it>P. aeruginosa</it>
BMC Bioinformatics
author_facet Guery Benoit
LeBerre Rozenne
Comet Jean-Paul
Bernot Gilles
Mérieau Annabelle
Filopon Didier
Polack Benoit
Guespin-Michel Janine
author_sort Guery Benoit
title Epigenetic acquisition of inducibility of type III cytotoxicity in <it>P. aeruginosa</it>
title_short Epigenetic acquisition of inducibility of type III cytotoxicity in <it>P. aeruginosa</it>
title_full Epigenetic acquisition of inducibility of type III cytotoxicity in <it>P. aeruginosa</it>
title_fullStr Epigenetic acquisition of inducibility of type III cytotoxicity in <it>P. aeruginosa</it>
title_full_unstemmed Epigenetic acquisition of inducibility of type III cytotoxicity in <it>P. aeruginosa</it>
title_sort epigenetic acquisition of inducibility of type iii cytotoxicity in <it>p. aeruginosa</it>
publisher BMC
series BMC Bioinformatics
issn 1471-2105
publishDate 2006-05-01
description <p>Abstract</p> <p>Background</p> <p><it>Pseudomonas aeruginosa</it>, an opportunistic pathogen, is often encountered in chronic lung diseases such as cystic fibrosis or chronic obstructive pneumonia, as well as acute settings like mechanical ventilation acquired pneumonia or neutropenic patients. It is a major cause of mortality and morbidity in these diseases. In lungs, <it>P. aeruginosa </it>settles in a biofilm mode of growth with the secretion of exopolysaccharides in which it is encapsulated, enhancing its antibiotic resistance and contributing to the respiratory deficiency of patients. However, bacteria must first multiply to a high density and display a cytotoxic phenotype to avoid the host's defences. A virulence determinant implicated in this step of infection is the type III secretion system (TTSS), allowing toxin injection directly into host cells. At the beginning of the infection, most strains isolated from patients' lungs possess an inducible TTSS allowing toxins injection or secretion upon <it>in vivo </it>or <it>in vitro </it>activation signals. As the infection persists most of the bacteria permanently loose this capacity, although no mutations have been evidenced. We name "non inducible" this phenotype. As suggested by the presence of a positive feedback circuit in the regulatory network controlling TTSS expression, it may be due to an epigenetic switch allowing heritable phenotypic modifications without genotype's mutations.</p> <p>Results</p> <p>Using the generalised logical method, we designed a minimal model of the TTSS regulatory network that could support the epigenetic hypothesis, and studied its dynamics which helped to define a discriminating experimental scenario sufficient to validate the epigenetic hypothesis. A mathematical framework based on formal methods from computer science allowed a rigorous validation and certification of parameters of this model leading to epigenetic behaviour. Then, we demonstrated that a non inducible strain of <it>P. aeruginosa </it>can stably acquire the capacity to be induced by calcium depletion for the TTSS after a short pulse of a regulatory protein. Finally, the increased cytotoxicity of a strain after this epigenetic switch was demonstrated <it>in vivo </it>in an acute pulmonary infection model.</p> <p>Conclusion</p> <p>These results may offer new perspectives for therapeutic strategies to prevent lethal infections by <it>P. aeruginosa </it>by reverting the epigenetic inducibility of type III cytotoxicity.</p>
url http://www.biomedcentral.com/1471-2105/7/272
work_keys_str_mv AT guerybenoit epigeneticacquisitionofinducibilityoftypeiiicytotoxicityinitpaeruginosait
AT leberrerozenne epigeneticacquisitionofinducibilityoftypeiiicytotoxicityinitpaeruginosait
AT cometjeanpaul epigeneticacquisitionofinducibilityoftypeiiicytotoxicityinitpaeruginosait
AT bernotgilles epigeneticacquisitionofinducibilityoftypeiiicytotoxicityinitpaeruginosait
AT merieauannabelle epigeneticacquisitionofinducibilityoftypeiiicytotoxicityinitpaeruginosait
AT filopondidier epigeneticacquisitionofinducibilityoftypeiiicytotoxicityinitpaeruginosait
AT polackbenoit epigeneticacquisitionofinducibilityoftypeiiicytotoxicityinitpaeruginosait
AT guespinmicheljanine epigeneticacquisitionofinducibilityoftypeiiicytotoxicityinitpaeruginosait
_version_ 1725303046548750336